{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:23:29Z","timestamp":1781796209552,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Jiaozuo City Medical Research Project under grant number","award":["2017KY018"],"award-info":[{"award-number":["2017KY018"]}]},{"name":"2021 Key Scientific and Technological Project of Henan Science and Technology Department","award":["202102310774"],"award-info":[{"award-number":["202102310774"]}]},{"name":"the Fundamental Research Funds for the Universities of Henan Province","award":["NSFRF220416"],"award-info":[{"award-number":["NSFRF220416"]}]},{"name":"2022 Key Scientific and Technological Project of Henan Science and Technology Department","award":["222102310340"],"award-info":[{"award-number":["222102310340"]}]},{"name":"2022 Key Scientific Research Project of Universities of Henan Education Department","award":["22A310015"],"award-info":[{"award-number":["22A310015"]}]},{"name":"Doctoral Fund Project of Henan Polytechnic University","award":["B2021-68"],"award-info":[{"award-number":["B2021-68"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Diabetic kidney disease (DKD) is the most common microvascular complication of diabetes, which has been a major cause of end-stage renal failure. Diagnosing diabetic kidney disease is important to prevent long-term kidney damage and determine the prognosis of patients with diabetes. In this study, we investigated the clinical significance of combined detection of urine orosomucoid and retinol-binding protein for early diagnosis of diabetic kidney disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We recruited 72 newly diagnosed patients with type 2 diabetes and 34 healthy persons from August 2016 to July 2018 at the First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People\u2019s Hospital). Using the Mogensen grading criteria, participants were classified as having diabetes or diabetic kidney disease, and healthy persons constituted the control group. Urine orosomucoid and retinol-binding protein levels were measured and correlated with other variables.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>With the aggravation of renal damage, the level of urinary mucoid protein gradually increased. Urinary retinol-binding protein and microalbumin levels were significantly higher in the diabetes group than in control and nephropathy groups. Orosomucoid and retinol-binding protein might be independent risk factors for diabetes and diabetic kidney disease. Urinary orosomucoid significantly correlated with retinol-binding protein and microalbumin levels in the diabetic kidney disease group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Elevated urine orosomucoid and retinol-binding protein levels can be detected in the early stages of type 2 diabetic kidney disease. Both of these markers are important for diabetic kidney disease detection and early treatment.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-023-03363-3","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T21:34:58Z","timestamp":1701725698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Urinary orosomucoid and retinol binding protein levels as early diagnostic markers for diabetic kidney Disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Xue-hong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-hua","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"issue":"1","key":"3363_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1373\/jalm.2018.028530","volume":"4","author":"GV Kapoula","year":"2019","unstructured":"Kapoula GV, Kontou PI, Bagos PG. Diagnostic accuracy of Neutrophil Gelatinase-Associated Lipocalin for Predicting Early Diabetic Nephropathy in patients with type 1 and type 2 Diabetes Mellitus: a systematic review and Meta-analysis. J Appl Lab Med. 2019;4(1):78\u201394.","journal-title":"J Appl Lab Med"},{"issue":"23","key":"3363_CR2","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.2169\/internalmedicine.1132-18","volume":"57","author":"K Furuichi","year":"2018","unstructured":"Furuichi K, Shimizu M, Hara A, Toyama T, Wada T. Diabetic Nephropathy: a comparison of the clinical and pathological features between the CKD Risk classification and the classification of Diabetic Nephropathy 2014 in Japan. Intern Med. 2018;57(23):3346\u201350.","journal-title":"Intern Med"},{"issue":"5","key":"3363_CR3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/10408363.2017.1377682","volume":"54","author":"N Papadopoulou-Marketou","year":"2017","unstructured":"Papadopoulou-Marketou N, Kanaka-Gantenbein C, Marketos N, Chrousos G, Papassotiriou I. Biomarkers of diabetic Nephropathy: a 2017 update. Crit Rev Clin Lab Sci. 2017;54(5):326\u201342.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"3","key":"3363_CR4","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1681\/ASN.2006070767","volume":"18","author":"S Varghese","year":"2007","unstructured":"Varghese S, Powell T, Budisavljevic M, Oates J, Raymond J, Almeida J, Arthur J. Urine biomarkers predict the cause of glomerular Disease. J Am Soc Nephrology: JASN. 2007;18(3):913\u201322.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"1\u20132","key":"3363_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.20452\/pamw.2640","volume":"125","author":"A Lewandowicz","year":"2015","unstructured":"Lewandowicz A, Bakun M, Kohutnicki R, Fabijanska A, Kistowski M, Imiela J, Dadlez M. Changes in urine proteome accompanying diabetic Nephropathy progression. Pol Arch Med Wewn. 2015;125(1\u20132):27\u201338.","journal-title":"Pol Arch Med Wewn"},{"issue":"8","key":"3363_CR6","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1177\/1076029616637185","volume":"22","author":"NMS El-Beblawy","year":"2016","unstructured":"El-Beblawy NMS, Andrawes NG, Ismail EAR, Enany ES, Abou El-Seoud HS, Erfan MA. Serum and urinary orosomucoid in young patients with type 1 Diabetes: a link between inflammation, Microvascular Complications, and subclinical Atherosclerosis. Clin Appl Thromb Hemost. 2016;22(8):718\u201326.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"9","key":"3363_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/nep.13707","volume":"25","author":"H Wang","year":"2020","unstructured":"Wang H, Bao X, Ma Y, Shan X, Huang C. Urinary orosomucoid 1 protein to creatinine ratio as a potential biomarker for early screening of kidney impairment in type-2 Diabetes patients. Nephrol (Carlton Vic). 2020;25(9):667\u201375.","journal-title":"Nephrol (Carlton Vic)"},{"key":"3363_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4137\/BMI.S33191","volume":"11","author":"M Mahfouz","year":"2016","unstructured":"Mahfouz M, Assiri A, Mukhtar M. Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and retinol-binding protein 4 (RBP4) in type 2 Diabetic patients with Nephropathy. Biomark Insights. 2016;11:31\u201340.","journal-title":"Biomark Insights"},{"key":"3363_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00508-022-02122-y","volume":"135","author":"J Harreiter","year":"2023","unstructured":"Harreiter J, Roden M. [Diabetes Mellitus: definition, classification, diagnosis, screening and prevention (update 2023)]. Wiener Klinische Wochenschrift. 2023;135:7\u201317.","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"9","key":"3363_CR10","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jdiacomp.2017.06.016","volume":"31","author":"A Schwandt","year":"2017","unstructured":"Schwandt A, Denkinger M, Fasching P, Pfeifer M, Wagner C, Weiland J, Zeyfang A, Holl R. Comparison of MDRD, CKD-EPI, and Cockcroft-Gault equation in relation to measured glomerular filtration rate among a large cohort with Diabetes. J Diabetes Complicat. 2017;31(9):1376\u201383.","journal-title":"J Diabetes Complicat"},{"issue":"11","key":"3363_CR11","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.2337\/dc11-0475","volume":"34","author":"G Nichols","year":"2011","unstructured":"Nichols G, Vupputuri S, Lau H. Medical care costs associated with progression of diabetic Nephropathy. Diabetes Care. 2011;34(11):2374\u20138.","journal-title":"Diabetes Care"},{"issue":"5","key":"3363_CR12","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/jdi.12828","volume":"9","author":"S Liu","year":"2018","unstructured":"Liu S, Chen J, Li Y. Clinical significance of serum interleukin-8 and soluble Tumor necrosis factor-like weak inducer of apoptosis levels in patients with diabetic Nephropathy. J Diabetes Invest. 2018;9(5):1182\u20138.","journal-title":"J Diabetes Invest"},{"issue":"2","key":"3363_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13105-015-0389-9","volume":"71","author":"Z Luo","year":"2015","unstructured":"Luo Z, Lei H, Sun Y, Liu X, Su D. Orosomucoid, an acute response protein with multiple modulating activities. J Physiol Biochem. 2015;71(2):329\u201340.","journal-title":"J Physiol Biochem"},{"key":"3363_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.mce.2015.08.025","volume":"416","author":"R Lage","year":"2015","unstructured":"Lage R, Moscoso I, Fern\u00e1ndez-Trasancos \u00c1, Cebro M, Couselo M, Fandi\u00f1o-Vaquero R, Bravo S, Sierra J, Gonz\u00e1lez-Juanatey J, Eiras S. Differential behaviour of epicardial adipose tissue-secretomes with high and low orosomucoid levels from patients with Cardiovascular Disease in H9C2 cells. Mol Cell Endocrinol. 2015;416:77\u201387.","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"3363_CR15","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1177\/1076029616637185","volume":"22","author":"N El-Beblawy","year":"2016","unstructured":"El-Beblawy N, Andrawes N, Ismail E, Enany B, El-Seoud H, Erfan M. Serum and urinary orosomucoid in young patients with type 1 Diabetes: a link between inflammation, Microvascular Complications, and subclinical Atherosclerosis. Clin Appl thrombosis\/hemostasis: Official J Int Acad Clin Appl Thrombosis\/Hemostasis. 2016;22(8):718\u201326.","journal-title":"Clin Appl thrombosis\/hemostasis: Official J Int Acad Clin Appl Thrombosis\/Hemostasis"},{"issue":"2","key":"3363_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2014.05.921","volume":"235","author":"R Fandi\u00f1o-Vaquero","year":"2014","unstructured":"Fandi\u00f1o-Vaquero R, Fern\u00e1ndez-Trasancos A, Alvarez E, Ahmad S, Batista-Oliveira A, Adrio B, Fern\u00e1ndez A, Gonz\u00e1lez-Juanatey J, Eiras S. Orosomucoid secretion levels by epicardial adipose tissue as possible indicator of endothelial dysfunction in Diabetes Mellitus or inflammation in coronary artery Disease. Atherosclerosis. 2014;235(2):281\u20138.","journal-title":"Atherosclerosis"},{"key":"3363_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2016.12.001","volume":"39","author":"M Andreucci","year":"2017","unstructured":"Andreucci M, Faga T, Pisani A, Perticone M, Michael A. The ischemic\/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice. Eur J Intern Med. 2017;39:1\u20138.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"3363_CR18","first-page":"246","volume":"44","author":"S Adiyanti","year":"2012","unstructured":"Adiyanti S, Loho T. Acute kidney Injury (AKI) biomarker. Acta Med Indones. 2012;44(3):246\u201355.","journal-title":"Acta Med Indones"},{"key":"3363_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/jrms.JRMS_893_17","volume":"23","author":"A Klisic","year":"2018","unstructured":"Klisic A, Kavaric N, Ninic A. Retinol-binding protein 4 versus albuminuria as predictors of estimated glomerular filtration rate decline in patients with type 2 Diabetes. J Res Med Sciences: Official J Isfahan Univ Med Sci. 2018;23:44.","journal-title":"J Res Med Sciences: Official J Isfahan Univ Med Sci"},{"key":"3363_CR20","doi-asserted-by":"crossref","unstructured":"Ni X, Gu Y, Yu H, Wang S, Chen Y, Wang X, Yuan X, Jia W. Serum Adipocyte Fatty Acid-Binding Protein 4 Levels Are Independently Associated with Radioisotope Glomerular Filtration Rate in Type 2 Diabetic Patients with Early Diabetic Nephropathy. BioMed research international 2018, 2018:4578140.","DOI":"10.1155\/2018\/4578140"},{"issue":"1","key":"3363_CR21","doi-asserted-by":"publisher","first-page":"e84708","DOI":"10.1371\/journal.pone.0084708","volume":"9","author":"N Pallet","year":"2014","unstructured":"Pallet N, Chauvet S, Chass\u00e9 J, Vincent M, Avillach P, Levi C, Meas-Yedid V, Olivo-Marin J, Nga-Matsogo D, Beaune P, et al. Urinary retinol binding protein is a marker of the extent of interstitial kidney fibrosis. PLoS ONE. 2014;9(1):e84708.","journal-title":"PLoS ONE"},{"issue":"2","key":"3363_CR22","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1159\/000477860","volume":"42","author":"J Wu","year":"2017","unstructured":"Wu J, Shao X, Lu K, Zhou J, Ren M, Xie X, Liu J, Xu Y, Ding Y, Shen X, et al. Urinary RBP and NGAL Levels Are Associated with Nephropathy in patients with type 2 Diabetes. Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol. 2017;42(2):594\u2013602.","journal-title":"Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03363-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03363-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03363-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T23:44:52Z","timestamp":1730763892000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03363-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3363"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03363-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,4]]},"assertion":[{"value":"2 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee of The First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People\u2019s Hospital) (IRB number: 2016010), and all patients provided written informed consent to participate in the study. All methods were carried out following relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"357"}}